These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35588621)

  • 1. Environmental obesogen: More considerations about the potential cause of obesity epidemic.
    Sun Z; Yang X; Liu QS; Lu B; Shi J; Zhou Q; Jiang G
    Ecotoxicol Environ Saf; 2022 Jul; 239():113613. PubMed ID: 35588621
    [No Abstract]   [Full Text] [Related]  

  • 2. The obesogen tributyltin.
    Grün F
    Vitam Horm; 2014; 94():277-325. PubMed ID: 24388195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental endocrine disruptors and obesity.
    Karoutsou E; Polymeris A
    Endocr Regul; 2012 Jan; 46(1):37-46. PubMed ID: 22329821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine disruptors and obesity.
    Heindel JJ; Newbold R; Schug TT
    Nat Rev Endocrinol; 2015 Nov; 11(11):653-61. PubMed ID: 26391979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers linking PCB exposure and obesity.
    Ghosh S; Murinova L; Trnovec T; Loffredo CA; Washington K; Mitra PS; Dutta SK
    Curr Pharm Biotechnol; 2014; 15(11):1058-68. PubMed ID: 25420728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The obesogen hypothesis: a shift of focus from the periphery to the hypothalamus.
    Decherf S; Demeneix BA
    J Toxicol Environ Health B Crit Rev; 2011; 14(5-7):423-48. PubMed ID: 21790320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental endocrine disruption of energy metabolism and cardiovascular risk.
    Kirkley AG; Sargis RM
    Curr Diab Rep; 2014 Jun; 14(6):494. PubMed ID: 24756343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between environmental endocrine-disrupting chemicals and obesity epidemic].
    Wang B; Zhou Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Apr; 47(4):297-300. PubMed ID: 23928632
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine disrupters as obesogens.
    Grün F; Blumberg B
    Mol Cell Endocrinol; 2009 May; 304(1-2):19-29. PubMed ID: 19433244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose effects of endocrine disruptors, with Laura Vandenberg. Interview by Ashley Ahearn.
    Vandenberg L
    Environ Health Perspect; 2012 Jun; 120(6):1 p preceding A228. PubMed ID: 22833914
    [No Abstract]   [Full Text] [Related]  

  • 11. An integrated approach to assess the role of chemical exposure in obesity.
    Legler J
    Obesity (Silver Spring); 2013 Jun; 21(6):1084-5. PubMed ID: 23595954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine disruptors cause toxic fallout.
    Holmes D
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):93-4. PubMed ID: 24622314
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesogens.
    Grün F
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):453-9. PubMed ID: 20689419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine Aspects of Environmental "Obesogen" Pollutants.
    Nappi F; Barrea L; Di Somma C; Savanelli MC; Muscogiuri G; Orio F; Savastano S
    Int J Environ Res Public Health; 2016 Jul; 13(8):. PubMed ID: 27483295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesogens, the exposome, and ES&T.
    Schnoor JL
    Environ Sci Technol; 2011 Apr; 45(7):2517. PubMed ID: 21395251
    [No Abstract]   [Full Text] [Related]  

  • 16. Reproductive effects of the parabens.
    Scialli AR
    Reprod Toxicol; 2011 Jul; 32(1):138-40; author reply 141. PubMed ID: 21440055
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to A critique of the European Commission Document, "State of the Art Assessment of Endocrine Disrupters" by Rhomberg and colleagues--letter to the editor.
    Kortenkamp A; Martin O; Evans R; Orton F; McKinlay R; Rosivatz E; Faust M
    Crit Rev Toxicol; 2012 Oct; 42(9):787-9; author reply 790-1. PubMed ID: 22900988
    [No Abstract]   [Full Text] [Related]  

  • 18. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
    Grün F; Blumberg B
    Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial overview: Endocrine and metabolic diseases: conversations on endocrine disruptors - rising above the din.
    Belcher SM
    Curr Opin Pharmacol; 2014 Dec; 19():vi-vii. PubMed ID: 25444363
    [No Abstract]   [Full Text] [Related]  

  • 20. Transgenerational inheritance of prenatal obesogen exposure.
    Janesick AS; Shioda T; Blumberg B
    Mol Cell Endocrinol; 2014 Dec; 398(1-2):31-5. PubMed ID: 25218215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.